Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2012, Article ID 681473, 15 pages
http://dx.doi.org/10.1155/2012/681473
Review Article

Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage

1Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences, 51/55 Twarda Street, 00818 Warsaw, Poland
2Institute of Experimental Internal Medicine, Otto von Guericke University, Leipziger Straße 44, 39120 Magdeburg, Germany
3Department of Internal Medicine I, Faculty of Medicine, University of Tübingen, Otfried-Müller-Straße 10, 72076 Tübingen, Germany

Received 1 August 2011; Revised 2 November 2011; Accepted 1 December 2011

Academic Editor: Lucia Andrade

Copyright © 2012 Justyna Bien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Yan and D. B. Polk, “Commensal bacteria in the gut: learning who our friends are,” Current Opinion in Gastroenterology, vol. 20, no. 6, pp. 565–571, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. J. B. Kaper, J. P. Nataro, and H. L. T. Mobley, “Pathogenic Escherichia coli,” Nature Reviews Microbiology, vol. 2, no. 2, pp. 123–140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. A. Russo and J. R. Johnson, “Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC,” Journal of Infectious Diseases, vol. 181, no. 5, pp. 1753–1754, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. T. J. Wiles, R. R. Kulesus, and M. A. Mulvey, “Origins and virulence mechanisms of uropathogenic Escherichia coli,” Experimental and Molecular Pathology, vol. 85, no. 1, pp. 11–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. E. Nicolle, “Urinary tract infection in geriatric and institutionalized patients,” Current Opinion in Urology, vol. 12, no. 1, pp. 51–55, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Foxman, “Epidemiology of urinary tract infections: incidence, morbidity, and economic costs,” Disease-a-Month, vol. 49, no. 2, pp. 53–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. B. W. Trautner, R. A. Hull, and R. O. Darouiche, “Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens,” Urology, vol. 61, no. 5, pp. 1059–1062, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. R. O. Darouiche, W. H. Donovan, M. Del Terzo, J. I. Thornby, D. C. Rudy, and R. A. Hull, “Pilot trial of bacterial interference for preventing urinary tract infection,” Urology, vol. 58, no. 3, pp. 339–344, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Hull, D. Rudy, W. Donovan et al., “Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients,” Journal of Urology, vol. 163, no. 3, pp. 872–877, 2000. View at Google Scholar · View at Scopus
  10. T. M. Hooton and W. E. Stamm, “Diagnosis and treatment of uncomplicated urinary tract infection,” Infectious Disease Clinics of North America, vol. 11, no. 3, pp. 551–581, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Svanborg and G. Godaly, “Bacterial virulence in urinary tract infection,” Infectious Disease Clinics of North America, vol. 11, no. 3, pp. 513–529, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Sadler, A. Chiang, T. Kurihara, J. Rothblatt, J. Way, and P. Silver, “A yeast gene important for protein assembly into the endoplasmic reticulum and the nucleus has homology to DnaJ, an Escherichia coli heat shock protein,” Journal of Cell Biology, vol. 109, no. 6 I, pp. 2665–2675, 1989. View at Publisher · View at Google Scholar · View at Scopus
  13. H. L. T. Mobley and J. W. Warren, Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, ASM Press, Washington, DC, USA, 1996.
  14. T. A. Russo, A. Stapleton, S. Wenderoth, T. M. Hooton, and W. E. Stamm, “Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women,” Journal of Infectious Diseases, vol. 172, no. 2, pp. 440–445, 1995. View at Google Scholar · View at Scopus
  15. A. R. Manges, J. R. Johnson, B. Foxman, T. T. O'Bryan, K. E. Fullerton, and L. W. Riley, “Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group,” New England Journal of Medicine, vol. 345, no. 14, pp. 1007–1013, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Mulvey, Y. S. Lopez-Boado, C. L. Wilson et al., “Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli,” Science, vol. 282, no. 5393, pp. 1494–1497, 1998. View at Google Scholar · View at Scopus
  17. J. J. Martinez, M. A. Mulvey, J. D. Schilling, J. S. Pinkner, and S. J. Hultgren, “Type 1 pilus-mediated bacterial invasion of bladder epithelial cells,” EMBO Journal, vol. 19, no. 12, pp. 2803–2812, 2000. View at Google Scholar · View at Scopus
  18. B. Kaijser and S. Ahlstedt, “Protective capacity of antibodies against Escherichia coli O and K antigens,” Infection and Immunity, vol. 17, no. 2, pp. 286–289, 1977. View at Google Scholar · View at Scopus
  19. C. Svanborg Eden, L. A. Hanson, and U. Jodal, “Variable adherence to normal human urinary tract epithelial cells of Escherichia coli strains associated with various forms of urinary tract infection,” Lancet, vol. 2, no. 7984, pp. 490–492, 1976. View at Google Scholar · View at Scopus
  20. U. Lindberg, L. A. Hanson, and U. Jodal, “Asymptomatic bacteriuria in schoolgirls—II. Differences in Escherichia coli causing asymptomatic and symptomatic bacteriuria,” Acta Paediatrica Scandinavica, vol. 64, no. 3, pp. 432–436, 1975. View at Google Scholar · View at Scopus
  21. P. Klemm, V. Roos, G. C. Ulett, C. Svanborg, and M. A. Schembri, “Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen,” Infection and Immunity, vol. 74, no. 1, pp. 781–785, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Roos, M. A. Schembri, G. C. Ulett, and P. Klemm, “Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae,” Microbiology, vol. 152, no. 6, pp. 1799–1806, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Scholes, T. M. Hooton, P. L. Roberts, K. Gupta, A. E. Stapleton, and W. E. Stamm, “Risk factors associated with acute pyelonephritis in healthy women,” Annals of Internal Medicine, vol. 142, no. 1, pp. 20–27, 2005. View at Google Scholar · View at Scopus
  24. N. E. Tolkoff-Rubin and R. H. Rubin, “Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic,” Infectious Disease Clinics of North America, vol. 11, no. 3, pp. 707–717, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. D. E. Ramsey, W. T. Finch, and A. G. Birtch, “Urinary tract infections in kidney transplant recipients,” Archives of Surgery, vol. 114, no. 9, pp. 1022–1025, 1979. View at Google Scholar · View at Scopus
  26. K. C. Abbott, J. D. Oliver, I. Hypolite et al., “Hospitalizations for bacterial septicemia after renal transplantation in the United States,” American Journal of Nephrology, vol. 21, no. 2, pp. 120–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. J. C. Rice, T. Peng, Y. F. Kuo et al., “Renal allograft injury is associated with urinary tract infection caused by Escherichia coli bearing adherence factors,” American Journal of Transplantation, vol. 6, no. 10, pp. 2375–2383, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. D. Schilling, S. M. Martin, C. S. Hung, R. G. Lorenz, and S. J. Hultgren, “Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 4203–4208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Hang, M. Haraoka, W. W. Agace et al., “Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract,” Journal of Immunology, vol. 162, no. 5, pp. 3037–3044, 1999. View at Google Scholar · View at Scopus
  30. J. M. Bower, D. S. Eto, and M. A. Mulvey, “Covert operations of uropathogenic Escherichia coli within the urinary tract,” Traffic, vol. 6, no. 1, pp. 18–31, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Mulvey, J. D. Schilling, J. J. Martinez, and S. J. Hultgren, “Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 8829–8835, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. T. A. Oelschlaeger, U. Dobrindt, and J. Hacker, “Pathogenicity islands of uropathogenic E. coli and the evolution of virulence,” International Journal of Antimicrobial Agents, vol. 19, no. 6, pp. 517–521, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Emödy, M. Kerényi, and G. Nagy, “Virulence factors of uropathogenic Escherichia coli,” International Journal of Antimicrobial Agents, vol. 22, no. 2, pp. S29–S33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. M. A. Mulvey, “Adhesion and entry of uropathogenic Escherichia coli,” Cellular Microbiology, vol. 4, no. 5, pp. 257–271, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Bergsten, B. Wullt, M. A. Schembri, I. Leijonhufvud, and C. Svanborg, “Do type 1 fimbriae promote inflammation in the human urinary tract?” Cellular Microbiology, vol. 9, no. 7, pp. 1766–1781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. J. A. Snyder, B. J. Haugen, E. L. Buckles et al., “Transcriptome of uropathogenic Escherichia coli during urinary tract infection,” Infection and Immunity, vol. 72, no. 11, pp. 6373–6381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Connell, W. Agace, P. Klemm, M. Schembri, S. Mårild, and C. Svanborg, “Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 18, pp. 9827–9832, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. S. J. Hultgren, T. N. Porter, A. J. Schaeffer, and J. L. Duncan, “Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli,” Infection and Immunity, vol. 50, no. 2, pp. 370–377, 1985. View at Google Scholar · View at Scopus
  39. L. Hagberg, I. Engberg, and R. Freter, “Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin,” Infection and Immunity, vol. 40, no. 1, pp. 273–283, 1983. View at Google Scholar · View at Scopus
  40. L. Hagberg, U. Jodal, and T. K. Korhonen, “Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections,” Infection and Immunity, vol. 31, no. 2, pp. 564–570, 1981. View at Google Scholar · View at Scopus
  41. J. P. Duguid and D. Old, “Adhesive properties of enterobacteriaceae,” in Bacterial Adherence, Receptors and Recognition, E. Beachey, Ed., pp. 185–217, Chapman & Hall, London, UK, 1980. View at Google Scholar
  42. K. Plos, H. Lomberg, S. Hull, I. Johansson, and C. Svanborg, “Escherichia coli in patients with renal scarring: genotype and phenotype of Galα1-4Galβ-, Forssman- and mannose-specific adhesins,” Pediatric Infectious Disease Journal, vol. 10, no. 1, pp. 15–19, 1991. View at Google Scholar
  43. G. G. Anderson, J. J. Palermo, J. D. Schilling, R. Roth, J. Heuser, and S. J. Hultgren, “Intracellular bacterial biofilm-like pods in urinary tract infections,” Science, vol. 301, no. 5629, pp. 105–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. T. A. Oelschlaeger, U. Dobrindt, and J. Hacker, “Virulence factors of uropathogens,” Current Opinion in Urology, vol. 12, no. 1, pp. 33–38, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. M. A. Schembri and P. Klemm, “Biofilm formation in a hydrodynamic environment by novel FimH variants and ramifications for virulence,” Infection and Immunity, vol. 69, no. 3, pp. 1322–1328, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Struve and K. A. Krogfelt, “In vivo detection of Escherichia coli type 1 fimbrial expression and phase variation during experimental urinary tract infection,” Microbiology, vol. 145, no. 10, pp. 2683–2690, 1999. View at Google Scholar · View at Scopus
  47. P. Thumbikat, R. E. Berry, G. Zhou et al., “Bacteria-induced uroplakin signaling mediates bladder response to infection,” PLoS Pathogens, vol. 5, no. 5, Article ID e1000415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. M. Bates, H. M. Raffi, K. Prasadan et al., “Tamm-Horsfall protein knockout mice are more prone to urinary tract infection,” Kidney International, vol. 65, no. 3, pp. 791–797, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Pak, Y. Pu, Z. T. Zhang, D. L. Hasty, and X. R. Wu, “Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors,” Journal of Biological Chemistry, vol. 276, no. 13, pp. 9924–9930, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Leffer and C. Svanborg-Eden, “Glycolipid receptors for uropathogenic Escherichia coli on human erthrocytes and uroepithelial cells,” Infection and Immunity, vol. 34, no. 3, pp. 920–929, 1981. View at Google Scholar · View at Scopus
  51. V. Vaisanen, J. Elo, and L. G. Tallgren, “Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis,” Lancet, vol. 2, no. 8260-8261, pp. 1366–1369, 1981. View at Google Scholar · View at Scopus
  52. K. Plos, H. Connell, U. Jodal et al., “Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children,” Journal of Infectious Diseases, vol. 171, no. 3, pp. 625–631, 1995. View at Google Scholar · View at Scopus
  53. G. Godaly, G. Bergsten, B. Frendéus et al., “Innate defences and resistance to gram negative mucosal infection,” Advances in Experimental Medicine and Biology, vol. 485, pp. 9–24, 2000. View at Google Scholar · View at Scopus
  54. M. Hedlund, C. Wachtler, E. Johansson et al., “P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses,” Molecular Microbiology, vol. 33, no. 4, pp. 693–703, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Leffler and C. Svanborg Eden, “Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes,” FEMS Microbiology Letters, vol. 8, no. 3, pp. 127–134, 1980. View at Publisher · View at Google Scholar · View at Scopus
  56. R. A. Hull, R. E. Gill, and P. Hsu, “Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate,” Infection and Immunity, vol. 33, no. 3, pp. 933–938, 1981. View at Google Scholar · View at Scopus
  57. B. Wullt, G. Bergsten, H. Connell et al., “P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract,” Molecular Microbiology, vol. 38, no. 3, pp. 456–464, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Fischer, P. Ellström, K. Ekström, L. Gustafsson, M. Gustafsson, and C. Svanborg, “Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4,” Cellular Microbiology, vol. 9, no. 5, pp. 1239–1251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Bergsten, B. Wullt, and C. Svanborg, “Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract,” International Journal of Medical Microbiology, vol. 295, no. 6-7, pp. 487–502, 2005. View at Publisher · View at Google Scholar
  60. K. Melican, R. M. Sandoval, A. Kader et al., “Uropathogenic Escherichia coli P and type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction,” PLoS Pathogens, vol. 7, no. 2, Article ID e1001298, 2011. View at Publisher · View at Google Scholar
  61. J. S. Hacker and J. Morschhäuser, in Fimbriae, Adhesion, Genetics, Biogenesis, and Vaccines, P. Klemm, Ed., pp. 27–36, CRC Press, Boca Raton, Fla, USA, 1994.
  62. R. Marre, B. Kreft, and J. Hacker, “Genetically engineered S and F1C fimbriae differ in their contribution to adherence of Escherichia coli to cultured renal tubular cells,” Infection and Immunity, vol. 58, no. 10, pp. 3434–3437, 1990. View at Google Scholar · View at Scopus
  63. A. L. Servin, “Pathogenesis of Afa/Dr diffusely adhering Escherichia coli,” Clinical Microbiology Reviews, vol. 18, no. 2, pp. 264–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. M. I. Garcia, P. Gounon, P. Courcoux, A. Labigne, and C. Le Bouguénec, “The afimbrial adhesive sheath encoded by the afa-3 gene cluster of pathogenic Escherichia coli is composed of two adhesins,” Molecular Microbiology, vol. 19, no. 4, pp. 683–693, 1996. View at Google Scholar · View at Scopus
  65. B. Foxman, L. Zhang, P. Tallman et al., “Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection,” Journal of Infectious Diseases, vol. 172, no. 6, pp. 1536–1541, 1995. View at Google Scholar · View at Scopus
  66. B. Nowicki, A. Labigne, S. Moseley, R. Hull, S. Hull, and J. Moulds, “The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition,” Infection and Immunity, vol. 58, no. 1, pp. 279–281, 1990. View at Google Scholar · View at Scopus
  67. B. Nowicki, R. Selvarangan, and S. Nowicki, “Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness,” Journal of Infectious Diseases, vol. 183, no. 1, pp. S24–S27, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Goluszko, S. L. Moseley, L. D. Truong et al., “Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae. Mutation in the dra region prevented tubulointerstitial nephritis,” Journal of Clinical Investigation, vol. 99, no. 7, pp. 1662–1672, 1997. View at Google Scholar · View at Scopus
  69. C. Le Bouguénec, “Adhesins and invasins of pathogenic Escherichia coli,” International Journal of Medical Microbiology, vol. 295, no. 6-7, pp. 471–478, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Nowicki, L. Truong, J. Moulds, and R. Hull, “Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection,” American Journal of Pathology, vol. 133, no. 1, pp. 1–4, 1988. View at Google Scholar · View at Scopus
  71. L. Lalioui and C. Le Bouguénec, “afa-8 Gene cluster is carried by a pathogenicity island inserted into the tRNAPhe of human and bovine pathogenic Escherichia coli isolates,” Infection and Immunity, vol. 69, no. 2, pp. 937–948, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. A. A. Salyers and D. D. Whitt, Bacterial Pathogenesis: a 6. Molecular Approach, ASM Press, Washington, DC, USA, 2002.
  73. J. R. Johnson, “Virulence factors in Escherichia coli urinary tract infection,” Clinical Microbiology Reviews, vol. 4, no. 1, pp. 80–128, 1991. View at Google Scholar · View at Scopus
  74. F. Bäckhed, M. Söderhäll, P. Ekman, S. Normark, and A. Richter-Dahlfors, “Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract,” Cellular Microbiology, vol. 3, no. 3, pp. 153–158, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. P. N. Cunningham, Y. Wang, R. Guo, G. He, and R. J. Quigg, “Role of Toll-like receptor 4 in endotoxin-induced acute renal failure,” Journal of Immunology, vol. 172, no. 4, pp. 2629–2635, 2004. View at Google Scholar · View at Scopus
  76. T. G. A. M. Wolfs, W. A. Buurman, A. Van Schadewijk et al., “In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α mediated up-regulation during inflammation,” Journal of Immunology, vol. 168, no. 3, pp. 1286–1293, 2002. View at Google Scholar · View at Scopus
  77. P. Samuelsson, L. Hang, B. Wullt, H. Irjala, and C. Svanborg, “Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa,” Infection and Immunity, vol. 72, no. 6, pp. 3179–3186, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Pichon, C. Héchard, L. Du Merle et al., “Uropathogenic Escherichia coli AL511 requires flagellum to enter renal collecting duct cells,” Cellular Microbiology, vol. 11, no. 4, pp. 616–628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. W. R. Schwan, “Flagella allow uropathogenic Escherichia coli ascension into murine kidneys,” International Journal of Medical Microbiology, vol. 298, no. 5-6, pp. 441–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. B. Eberspacher, F. Hugo, and S. Bhakdi, “Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin,” Infection and Immunity, vol. 57, no. 3, pp. 983–988, 1989. View at Google Scholar · View at Scopus
  81. S. Bhakdi, N. Mackman, J. M. Nicaud, and I. B. Holland, “Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores,” Infection and Immunity, vol. 52, no. 1, pp. 63–69, 1986. View at Google Scholar · View at Scopus
  82. A. Laestadius, A. Richter-Dahlfors, and A. Aperia, “Dual effects of Escherichia coliα-hemolysin on rat renal proximal tubule cells,” Kidney International, vol. 62, no. 6, pp. 2035–2042, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. W. F. Keane, R. Welch, G. Gekker, and P. K. Peterson, “Mechanism of Escherichia coliα-hemolysin-induced injury to isolated renal tubular cells,” American Journal of Pathology, vol. 126, no. 2, pp. 350–357, 1987. View at Google Scholar · View at Scopus
  84. S. J. Cavalieri, G. A. Bohach, and I. S. Snyder, “Escherichia coliα-hemolysin: characteristics and probable role in pathogenicity,” Microbiological Reviews, vol. 48, no. 4, pp. 326–343, 1984. View at Google Scholar · View at Scopus
  85. M. Chen, R. Tofighi, W. Bao et al., “Carbon monoxide prevents apoptosis induced by uropathogenic Escherichia coli toxins,” Pediatric Nephrology, vol. 21, no. 3, pp. 382–389, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. C. Smith, K. K. Grande, S. B. Rasmussen, and A. D. O'Brien, “Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells,” Infection and Immunity, vol. 74, no. 1, pp. 750–757, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. T. A. Russo, B. A. Davidson, S. A. Genagon et al., “E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model,” American Journal of Physiology, vol. 289, no. 2, pp. L207–L216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. D. Jonas, B. Schultheis, C. Klas, P. H. Krammer, and S. Bhakdi, “Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes,” Infection and Immunity, vol. 61, no. 5, pp. 1715–1721, 1993. View at Google Scholar · View at Scopus
  89. P. Uhlén, Å. Laestadius, T. Jahnukalnen et al., “α-Haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells,” Nature, vol. 405, no. 6787, pp. 694–697, 2000. View at Publisher · View at Google Scholar · View at Scopus
  90. D. E. Kohan, “Role of endothelin and tumour necrosis factor in the renal response to sepsis,” Nephrology Dialysis Transplantation, vol. 9, no. 4, pp. 73–77, 1994. View at Google Scholar · View at Scopus
  91. B. Jakobsson, U. Berg, and L. Svensson, “Renal scarring after acute pyelonephritis,” Archives of Disease in Childhood, vol. 70, no. 2, pp. 111–115, 1994. View at Google Scholar · View at Scopus
  92. M. R. Ditchfield, J. F. De Campo, T. M. Nolan et al., “Risk factors in the development of early renal cortical defects in children with urinary tract infection,” American Journal of Roentgenology, vol. 162, no. 6, pp. 1393–1397, 1994. View at Google Scholar · View at Scopus
  93. H. L. Mobley, D. M. Green, A. L. Trifillis et al., “Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains,” Infection and Immunity, vol. 58, no. 5, pp. 1281–1289, 1990. View at Google Scholar · View at Scopus
  94. M. Chen, T. Jahnukainen, W. Bao, E. Daré, S. Ceccatelli, and G. Celsi, “Uropathogenic Escherichia coli toxins induce caspase-independent apoptosis in renal proximal tubular cells via ERK signaling,” American Journal of Nephrology, vol. 23, no. 3, pp. 140–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. L. Landraud, M. Gauthier, T. Fosse, and P. Boquet, “Frequency of Escherichia coli strains producing the cytotoxic necrotizing factor (CNF1) in nosocomial urinary tract infections,” Letters in Applied Microbiology, vol. 30, no. 3, pp. 213–216, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. J. De Rycke, A. Milon, and E. Oswald, “Necrotoxic Escherichia coli (NTEC): two emerging categories of human and animal pathogens,” Veterinary Research, vol. 30, no. 2-3, pp. 221–233, 1999. View at Google Scholar · View at Scopus
  97. M. Mills, K. C. Meysick, and A. D. O'Brien, “Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism,” Infection and Immunity, vol. 68, no. 10, pp. 5869–5880, 2000. View at Publisher · View at Google Scholar · View at Scopus
  98. C. Fiorentini, A. Fabbri, P. Matarrese, L. Falzano, P. Boquet, and W. Malorni, “Hinderance of apoptosis and phagocytic behaviour induced by Escherichia coli cytotoxic necrotizing factor 1. Two related activities in epithelial cells,” Biochemical and Biophysical Research Communications, vol. 241, no. 2, pp. 341–346, 1997. View at Publisher · View at Google Scholar · View at Scopus
  99. D. M. Guyer, S. Radulovic, F. E. Jones, and H. L. T. Mobley, “Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells,” Infection and Immunity, vol. 70, no. 8, pp. 4539–4546, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. D. M. Guyer, I. R. Henderson, J. P. Nataro, and H. L. T. Mobley, “Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli,” Molecular Microbiology, vol. 38, no. 1, pp. 53–66, 2000. View at Publisher · View at Google Scholar · View at Scopus
  101. C. P. Féria, J. D. Correia, J. Gonçalves, and J. Machado, “Detection of virulence factors in uropathogenic Escherichia coli isolated from humans, dogs and cats in Portugal,” Advances in Experimental Medicine and Biology, vol. 485, pp. 305–308, 2000. View at Google Scholar · View at Scopus
  102. I. Tóth, F. Hérault, L. Beutin, and E. Oswald, “Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type IV),” Journal of Clinical Microbiology, vol. 41, no. 9, pp. 4285–4291, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. C. Cirl, A. Wieser, M. Yadav et al., “Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins,” Nature Medicine, vol. 14, no. 4, pp. 399–406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Pizarro-Cerdá and P. Cossart, “Bacterial adhesion and entry into host cells,” Cell, vol. 124, no. 4, pp. 715–727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. J. D. Sobel, “Pathogenesis of urinary tract infection. Role of host defenses,” Infectious Disease Clinics of North America, vol. 11, no. 3, pp. 531–549, 1997. View at Publisher · View at Google Scholar · View at Scopus
  106. S. I. Fukuoka and K. I. Kobayashi, “Analysis of the C-terminal structure of urinary Tamm-Horsfall protein reveals that the release of the glycosyl phosphatidylinositol-anchored counterpart from the kidney occurs by phenylalanine-specific proteolysis,” Biochemical and Biophysical Research Communications, vol. 289, no. 5, pp. 1044–1048, 2001. View at Publisher · View at Google Scholar · View at Scopus
  107. D. Cavallone, N. Malagolini, and F. Serafini-Cessi, “Mechanism of release of urinary Tamm-Horsfall glycoprotein from the kidney GPI-anchored counterpart,” Biochemical and Biophysical Research Communications, vol. 280, no. 1, pp. 110–114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  108. S. I. Fukuoka, S. D. Freedman, H. Yu, V. P. Sukhatme, and G. A. Scheele, “GP-2/THP gene family encodes self-binding glycosylphosphatidylinositol- anchored proteins in apical secretory compartments of pancreas and kidney,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 4, pp. 1189–1193, 1992. View at Google Scholar · View at Scopus
  109. A. Leeker, B. Kreft, J. Sandmann et al., “Tamm-Horsfall protein inhibits binding of S- and P-fimbriated Escherichia coli to human renal tubular epithelial cells,” Experimental Nephrology, vol. 5, no. 1, pp. 38–46, 1997. View at Google Scholar · View at Scopus
  110. T. Ganz, “Defensins: antimicrobial peptides of innate immunity,” Nature Reviews Immunology, vol. 3, no. 9, pp. 710–720, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. Y. Fukushi, S. Orikasa, and M. Kagayama, “An electron microscopic study of the interaction between vesical epithelium and E. coli,” Investigative Urology, vol. 17, no. 1, pp. 61–68, 1979. View at Google Scholar · View at Scopus
  112. I. U. Mysorekar, M. A. Mulvey, S. J. Hultgren, and J. I. Gordon, “Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli,” Journal of Biological Chemistry, vol. 277, no. 9, pp. 7412–7419, 2002. View at Publisher · View at Google Scholar · View at Scopus
  113. D. J. Klumpp, A. C. Weiser, S. Sengupta, S. G. Forrestal, R. A. Batler, and A. J. Schaeffer, “Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-κB,” Infection and Immunity, vol. 69, no. 11, pp. 6689–6695, 2001. View at Publisher · View at Google Scholar · View at Scopus
  114. M. A. Mulvey, J. D. Schilling, and S. J. Hultgren, “Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection,” Infection and Immunity, vol. 69, no. 7, pp. 4572–4579, 2001. View at Publisher · View at Google Scholar · View at Scopus
  115. H.-J. Anders and P. S. Patole, “Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract,” Nephrology Dialysis Transplantation, vol. 20, no. 8, pp. 1529–1532, 2005. View at Publisher · View at Google Scholar
  116. M. Haraoka, L. Hang, B. Frendéus et al., “Neutrophil recruitment and resistance to urinary tract infection,” Journal of Infectious Diseases, vol. 180, no. 4, pp. 1220–1229, 1999. View at Publisher · View at Google Scholar · View at Scopus
  117. J. D. Schilling, S. M. Martin, D. A. Hunstad et al., “CD14- and toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli,” Infection and Immunity, vol. 71, no. 3, pp. 1470–1480, 2003. View at Publisher · View at Google Scholar · View at Scopus
  118. J. D. Schilling, M. A. Mulvey, C. D. Vincent, R. G. Lorenz, and S. J. Hultgren, “Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism,” Journal of Immunology, vol. 166, no. 2, pp. 1148–1155, 2001. View at Google Scholar · View at Scopus
  119. W. Agace, S. Hedges, U. Andersson, J. Andersson, M. Ceska, and C. Svanborg, “Selective cytokine production by epithelial cells following exposure to Escherichia coli,” Infection and Immunity, vol. 61, no. 2, pp. 602–609, 1993. View at Google Scholar · View at Scopus
  120. B. A. Jantausch, R. O'Donnell, and B. L. Wiedermann, “Urinary interleukin-6 and interleukin-8 in children with urinary tract infection,” Pediatric Nephrology, vol. 15, no. 3-4, pp. 236–240, 2000. View at Publisher · View at Google Scholar · View at Scopus
  121. G. Otto, J. H. Braconier, A. Andreasson, and C. Svanborg, “Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection,” Journal of Infectious Diseases, vol. 179, no. 1, pp. 172–179, 1999. View at Publisher · View at Google Scholar · View at Scopus
  122. Y. C. Ko, N. Mukaida, S. Ishiyama et al., “Elevated interleukin-8 levels in the urine of patients with urinary tract infections,” Infection and Immunity, vol. 61, no. 4, pp. 1307–1314, 1993. View at Google Scholar · View at Scopus
  123. S. Hedges, P. Anderson, G. Lidin-Janson, P. De Man, and C. Svanborg, “Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria,” Infection and Immunity, vol. 59, no. 1, pp. 421–427, 1991. View at Google Scholar · View at Scopus
  124. C. Gabay, “Interleukin-6 and chronic inflammation,” Arthritis Research and Therapy, vol. 8, no. 2, p. 3, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Benson, U. Jodal, W. Agace et al., “Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria,” Journal of Infectious Diseases, vol. 174, no. 5, pp. 1080–1084, 1996. View at Google Scholar · View at Scopus
  126. S. A. Cotton, R. A. Gbadegesin, C. J. Watson, P. E. C. Brenchley, and N. S. A. Webb, “Association between pro-inflammatory cytokines IL-6, IL-1b, IL-1RA and TNF-a gene polymorphisms and acute pyelonephritis following childhood urinary tract infection,” Journal of the American Society of Nephrology, vol. 11, p. 558, 2000. View at Google Scholar
  127. K. E. Sivick, M. A. Schaller, S. N. Smith, and H. L. T. Mobley, “The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection,” Journal of Immunology, vol. 184, no. 4, pp. 2065–2075, 2010. View at Publisher · View at Google Scholar · View at Scopus
  128. E. Andersen-Nissen, T. R. Hawn, K. D. Smith et al., “Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection,” Journal of Immunology, vol. 178, no. 8, pp. 4717–4720, 2007. View at Google Scholar · View at Scopus
  129. D. Zhang, G. Zhang, M. S. Hayden et al., “A Toll-like receptor that prevent infection by uropathogenic bacteria,” Science, vol. 303, no. 5663, pp. 1522–1526, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. B. Frendéus, C. Wachtler, M. Hedlund et al., “Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation,” Molecular Microbiology, vol. 40, no. 1, pp. 37–51, 2001. View at Publisher · View at Google Scholar · View at Scopus
  131. M. Hedlund, B. Frendéus, C. Wachtler, L. Hang, H. Fischer, and C. Svanborg, “Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells,” Molecular Microbiology, vol. 39, no. 3, pp. 542–552, 2001. View at Publisher · View at Google Scholar · View at Scopus
  132. J. Song and S. N. Abraham, “Innate and adaptive immune responses in the urinary tract,” European Journal of Clinical Investigation, vol. 38, no. 2, pp. 21–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. J. Song, M. J. Duncan, G. Li et al., “A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells.,” PLoS Pathogens, vol. 3, no. 4, Article ID 0030060, 2007. View at Publisher · View at Google Scholar · View at Scopus
  134. K. A. Fitzgerald, D. C. Rowe, B. J. Barnes et al., “LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF,” Journal of Experimental Medicine, vol. 198, no. 7, pp. 1043–1055, 2003. View at Publisher · View at Google Scholar · View at Scopus
  135. T. Kawai, O. Takeuchi, T. Fujita et al., “Lipopolysaccharide stimulates the MyaD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes,” Journal of Immunology, vol. 167, no. 10, pp. 5887–5894, 2001. View at Google Scholar · View at Scopus
  136. J. Hiscott, P. Pitha, P. Genin et al., “Triggering the interferon response: the role of IRF-3 transcription factor,” Journal of Interferon and Cytokine Research, vol. 19, no. 1, pp. 1–13, 1999. View at Publisher · View at Google Scholar · View at Scopus
  137. W. C. Au, P. A. Moore, W. Lowther, Y. T. Juang, and P. M. Pitha, “Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 25, pp. 11657–11661, 1995. View at Publisher · View at Google Scholar · View at Scopus
  138. C. Svanborg, B. Frendéus, G. Godaly, L. Hang, M. Hedlund, and C. Wachtler, “Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection,” Journal of Infectious Diseases, vol. 183, no. 1, pp. S61–S65, 2001. View at Publisher · View at Google Scholar · View at Scopus
  139. S. Hedges, M. Svensson, and C. Svanborg, “Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro,” Infection and Immunity, vol. 60, no. 4, pp. 1295–1301, 1992. View at Google Scholar · View at Scopus
  140. M. Hedlund, M. Svensson, A. Nilsson, R. D. Duan, and C. Svanborg, “Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli,” Journal of Experimental Medicine, vol. 183, no. 3, pp. 1037–1044, 1996. View at Google Scholar · View at Scopus
  141. H. Fischer, N. Lutay, B. Ragnarsdóttir et al., “Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection,” PLoS Pathogens, vol. 6, no. 9, Article ID e1001109, 2010. View at Publisher · View at Google Scholar
  142. A. A. Ashkar, K. L. Mossman, B. K. Coombes, C. L. Gyles, and R. Mackenzie, “FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling,” PLoS Pathogens, vol. 4, no. 12, Article ID e1000233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  143. K. L. Mossman, M. F. Mian, N. M. Lauzon et al., “Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand,” Journal of Immunology, vol. 181, no. 10, pp. 6702–6706, 2008. View at Google Scholar · View at Scopus
  144. K. Miyake, “Invited review: roles for accessory molecules in microbial recognition by Toll-like receptors,” Journal of Endotoxin Research, vol. 12, no. 4, pp. 195–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  145. M. Yamamoto, S. Sato, H. Hemmi et al., “Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4,” Nature, vol. 420, no. 6913, pp. 324–329, 2002. View at Publisher · View at Google Scholar · View at Scopus
  146. M. C. Lane, C. J. Alteri, S. N. Smith, and H. L. T. Mobley, “Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 42, pp. 16669–16674, 2007. View at Publisher · View at Google Scholar · View at Scopus
  147. E. Lorenz, J. P. Mira, K. L. Frees, and D. A. Schwartz, “Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock,” Archives of Internal Medicine, vol. 162, no. 9, pp. 1028–1032, 2002. View at Google Scholar · View at Scopus
  148. B. Ragnarsdóttir, K. Jönsson, A. Urbano et al., “Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection,” PLoS ONE, vol. 5, no. 5, Article ID e10734, 2010. View at Publisher · View at Google Scholar
  149. T. R. Hawn, A. Verbon, K. D. Lettinga et al., “A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease,” Journal of Experimental Medicine, vol. 198, no. 10, pp. 1563–1572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  150. L. E. Nee, T. McMorrow, E. Campbell, C. Slattery, and M. P. Ryan, “TNF-α and IL-1β-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells,” Kidney International, vol. 66, no. 4, pp. 1376–1386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  151. S. A. Cotton, R. A. Gbadegesin, S. Williams et al., “Role of TGF-β1 in renal parenchymal scarring following childhood urinary tract infection,” Kidney International, vol. 61, no. 1, pp. 61–67, 2002. View at Publisher · View at Google Scholar · View at Scopus
  152. W. A. Border and N. A. Noble, “Transforming growth factor β in tissue fibrosis,” New England Journal of Medicine, vol. 331, no. 19, pp. 1286–1292, 1994. View at Publisher · View at Google Scholar · View at Scopus
  153. R. E. Dolmetsch, R. S. Lewis, C. C. Goodnow, and J. I. Healy, “Differential activation of transcription factors induced by Ca2+ response amplitude and duration,” Nature, vol. 386, no. 6627, pp. 855–858, 1997. View at Google Scholar · View at Scopus
  154. A. J. Laude and A. W. M. Simpson, “Compartmentalized signalling: Ca2+ compartments, microdomains and the many facets of Ca2+ signalling,” FEBS Journal, vol. 276, no. 7, pp. 1800–1816, 2009. View at Publisher · View at Google Scholar · View at Scopus
  155. G. TranVan Nhieu, C. Clair, G. Grompone, and P. Sansonetti, “Calcium signalling during cell interactions with bacterial pathogens,” Biology of the Cell, vol. 96, no. 1, pp. 93–101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  156. M. J. Berridge, M. D. Bootman, and H. L. Roderick, “Calcium signalling: dynamics, homeostasis and remodelling,” Nature Reviews Molecular Cell Biology, vol. 4, no. 7, pp. 517–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  157. T. Söderblom, A. Laestadius, C. Oxhamre, A. Aperia, and A. Richter-Dahlfors, “Toxin-induced calcium oscillations: a novel strategy to affect gene regulation in target cells,” International Journal of Medical Microbiology, vol. 291, no. 6-7, pp. 511–515, 2001. View at Google Scholar
  158. T. Söderblom, C. Oxhamre, E. Torstensson, and A. Richter-Dahlfors, “Bacterial protein toxins and inflammation,” Scandinavian Journal of Infectious Diseases, vol. 35, no. 9, pp. 628–631, 2003. View at Publisher · View at Google Scholar · View at Scopus
  159. C. J. Czuprynski and R. A. Welch, “Biological effects of RTX toxins: the possible role of lipopolysaccharide,” Trends in Microbiology, vol. 3, no. 12, pp. 480–483, 1995. View at Publisher · View at Google Scholar · View at Scopus
  160. G. A. Bohach and I. S. Snyder, “Chemical and immunological analysis of the complex structure of Escherichia coli alpha-hemolysin,” Journal of Bacteriology, vol. 164, no. 3, pp. 1071–1080, 1985. View at Google Scholar · View at Scopus
  161. L. E. Månsson, P. Kjäll, S. Pellett et al., “Role of the lipopolysaccharide-CD14 complex for the activity of hemolysin from uropathogenic Escherichia coli,” Infection and Immunity, vol. 75, no. 2, pp. 997–1004, 2007. View at Publisher · View at Google Scholar · View at Scopus
  162. A. J. Shaywitz and M. E. Greenberg, “CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals,” Annual Review of Biochemistry, vol. 68, pp. 821–861, 1999. View at Publisher · View at Google Scholar · View at Scopus
  163. D. M. F. Cooper and K. Mons Fagan, “Ca2+-sensitive adenylyl cyclases,” Cellular Signalling, vol. 6, no. 8, pp. 823–840, 1994. View at Google Scholar · View at Scopus
  164. E. J. Choi, Z. Xia, and D. R. Storm, “Stimulation of the type III olfactory adenylyl cyclase by calcium and calmodulin,” Biochemistry, vol. 31, no. 28, pp. 6492–6498, 1992. View at Google Scholar · View at Scopus
  165. O. M. Andrisani, “CREB-mediated transcriptional control,” Critical Reviews in Eukaryotic Gene Expression, vol. 9, no. 1, pp. 19–32, 1999. View at Google Scholar · View at Scopus
  166. N. Mori, F. Shirakawa, H. Shimizu et al., “Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: evidence for the involvement of NF-κB,” Blood, vol. 84, no. 9, pp. 2904–2911, 1994. View at Google Scholar · View at Scopus
  167. J. B. Bliska, J. E. Galan, and S. Falkow, “Signal transduction in the mammalian cell during bacterial attachment and entry,” Cell, vol. 73, no. 5, pp. 903–920, 1993. View at Publisher · View at Google Scholar · View at Scopus
  168. D. S. Eto, H. B. Gordon, B. K. Dhakal, T. A. Jones, and M. A. Mulvey, “Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells,” Cellular Microbiology, vol. 10, no. 12, pp. 2553–2567, 2008. View at Publisher · View at Google Scholar · View at Scopus
  169. B. K. Billips, A. J. Schaeffer, and D. J. Klumpp, “Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder,” Infection and Immunity, vol. 76, no. 9, pp. 3891–3900, 2008. View at Publisher · View at Google Scholar · View at Scopus
  170. B. K. Billips, S. G. Forrestal, M. T. Rycyk, J. R. Johnson, D. J. Klumpp, and A. J. Schaeffer, “Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli,” Infection and Immunity, vol. 75, no. 11, pp. 5353–5360, 2007. View at Publisher · View at Google Scholar · View at Scopus
  171. D. J. Klumpp, M. T. Rycyk, M. C. Chen, P. Thumbikat, S. Sengupta, and A. J. Schaeffer, “Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis,” Infection and Immunity, vol. 74, no. 9, pp. 5106–5113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  172. D. A. Hunstad, S. S. Justice, C. S. Hung, S. R. Lauer, and S. J. Hultgren, “Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli,” Infection and Immunity, vol. 73, no. 7, pp. 3999–4006, 2005. View at Publisher · View at Google Scholar · View at Scopus
  173. D. W. Hilbert, K. E. Pascal, E. K. Libby, E. Mordechai, M. E. Adelson, and J. P. Trama, “Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway,” Microbes and Infection, vol. 10, no. 2, pp. 114–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  174. M. Yadav, J. Zhang, H. Fischer et al., “Inhibition of TIR domain signaling by TcpC: MyD88—dependent and independent effects on Escherichia coli virulence,” PLoS Pathogens, vol. 6, no. 9, Article ID e01120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. J. A. Loughman and D. A. Hunstad, “Attenuation of human neutrophil migration and function by uropathogenic bacteria,” Microbes and Infection, vol. 13, no. 6, pp. 555–565, 2011. View at Publisher · View at Google Scholar
  176. H.-J. Anders, B. Banas, and D. Schlöndorff, “Signaling danger: toll-like receptors and their potential roles in kidney disease,” Journal of the American Society of Nephrology, vol. 15, no. 4, pp. 854–867, 2004. View at Publisher · View at Google Scholar
  177. R. D. Pawar, P. S. Patole, M. Wörnle, and H.-J. Anders, “Microbial nucleic acids pay a Toll in kidney disease,” American Journal of Physiology, vol. 291, no. 3, pp. F509–F516, 2006. View at Publisher · View at Google Scholar
  178. A. Vandewalle, “Role of TLRs in renal tubule epithelial cells,” Chang Gung Medical Journal, vol. 31, pp. 525–537, 2008. View at Google Scholar
  179. J. W. Warren, “Clinical presentation and epidemiology of urinary tract infections,” in Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, H. L. T. Mobley and J. W. Warren, Eds., pp. 3–27, ASM Press, Washington, DC, USA, 1996. View at Google Scholar
  180. B. Foxman, R. Barlow, H. D'Arcy, B. Gillespie, and J. D. Sobel, “Urinary tract infection: self-reported incidence and associated costs,” Annals of Epidemiology, vol. 10, no. 8, pp. 509–515, 2000. View at Publisher · View at Google Scholar · View at Scopus
  181. S. Hellerstein, “Long-term consequences of urinary tract infections,” Current Opinion in Pediatrics, vol. 12, no. 2, pp. 125–128, 2000. View at Publisher · View at Google Scholar · View at Scopus
  182. M. Rosenberg, “Pharmacoeconomics of treating uncomplicated urinary tract infections,” International Journal of Antimicrobial Agents, vol. 11, no. 3-4, pp. 247–251, 1999. View at Publisher · View at Google Scholar · View at Scopus
  183. S. M. Tenner, M. W. Yadven, and P. L. Kimmel, “Acute pyelonephritis: preventing complications through prompt diagnosis and proper therapy,” Postgraduate Medicine, vol. 91, no. 2, pp. 261–268, 1992. View at Google Scholar · View at Scopus
  184. P. Orellana, P. Baquedano, V. Rangarajan et al., “Relationship between acute pyelonephritis, renal scarring, and vesicoureteral reflux. Results of a coordinated research project,” Pediatric Nephrology, vol. 19, no. 10, pp. 1122–1126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  185. L. Ghiro, A. T. Cracco, M. Sartor, S. Comacchio, G. Zacchello, and R. Dall'Amico, “Retrospective study of children with acute pyelonephritis: evaluation of bacterial etiology, antimicrobial susceptibility, drug management and imaging studies,” Nephron, vol. 90, no. 1, pp. 8–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  186. R. H. Heptinstall, “Pyelonephritis: pathologic features,” in Pathology of the Kidney, R. Heptinstall, Ed., pp. 1323–1396, Little, Brown and Company, Boston, Mass, USA, 3rd edition, 1983. View at Google Scholar
  187. L. Lyerová, J. Lácha, J. Skibová, V. Teplan, and S. Vítko, “Urinary tract infection in patients with urological complications after renal transplantation with respect to long-term function and allograft survival,” Annals of Transplantation, vol. 6, no. 2, pp. 19–20, 2001. View at Google Scholar